Affiliations: [a] Study Program of Master in Biomedical Science, Faculty of Medicine, Universitas Brawijaya Malang, Malang, Indonesia
| [b] Department of Radiology, Faculty of Medicine, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia
| [c] Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Brawijaya, Malang, Indonesia
| [d] Department of Radiology, Faculty of Medicine, Sebelas Maret University, Dr. Moewardi Hospital, Surakarta, Indonesia
Correspondence:
[*]
Corresponding author: Adam Fauzi Akbar, Study Program of Master in Biomedical Science, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia. E-mail: adamfauzi99@student.ub.ac.id.
Abstract: BACKGROUND:Malignant Primary Brain Tumor (MPBT) and Metastatic Brain Tumor (MBT) are the most common types of brain tumors, which require different management approaches. Magnetic Resonance Imaging (MRI) is the most frequently used modality for assessing the presence of these tumors. The utilization of Deep Learning (DL) is expected to assist clinicians in classifying MPBT and MBT more effectively. OBJECTIVE:This study aims to examine the influence of MRI sequences on the classification performance of DL techniques for distinguishing between MPBT and MBT and analyze the results from a medical perspective. METHODS:Total 1,360 images performed from 4 different MRI sequences were collected and preprocessed. VGG19 and ResNet101 models were trained and evaluated using consistent parameters. The performance of the models was assessed using accuracy, sensitivity, and other precision metrics based on a confusion matrix analysis. RESULTS:The ResNet101 model achieves the highest accuracy of 83% for MPBT classification, correctly identifying 90 out of 102 images. The VGG19 model achieves an accuracy of 81% for MBT classification, accurately classifying 86 out of 102 images. T2 sequence shows the highest sensitivity for MPBT, while T1C and T1 sequences exhibit the highest sensitivity for MBT. CONCLUSIONS:DL models, particularly ResNet101 and VGG19, demonstrate promising performance in classifying MPBT and MBT based on MRI images. The choice of MRI sequence can impact the sensitivity of tumor detection. These findings contribute to the advancement of DL-based brain tumor classification and its potential in improving patient outcomes and healthcare efficiency.
